Epidemiology and natural history of atrial fibrillation: Clinical implications

Sumeet S. Chugh, Joseph L. Blackshear, Win Kuang Shen, Stephen C. Hammill, Bernard J. Gersh

Research output: Contribution to journalArticle

547 Citations (Scopus)

Abstract

With a substantial impact on morbidity and mortality, the growing "epidemic" of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.

Original languageEnglish (US)
Pages (from-to)371-378
Number of pages8
JournalJournal of the American College of Cardiology
Volume37
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Atrial Fibrillation
Epidemiology
Cardiac Arrhythmias
Atrial Remodeling
Knowledge Bases
Resource Allocation
Thromboembolism
Left Ventricular Dysfunction
Genomics
Ion Channels
Molecular Biology
Decision Making
Therapeutics
Hemorrhage
Hypertension
Morbidity
Phenotype
Mutation
Mortality
Population

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Epidemiology and natural history of atrial fibrillation : Clinical implications. / Chugh, Sumeet S.; Blackshear, Joseph L.; Shen, Win Kuang; Hammill, Stephen C.; Gersh, Bernard J.

In: Journal of the American College of Cardiology, Vol. 37, No. 2, 2001, p. 371-378.

Research output: Contribution to journalArticle

Chugh, Sumeet S. ; Blackshear, Joseph L. ; Shen, Win Kuang ; Hammill, Stephen C. ; Gersh, Bernard J. / Epidemiology and natural history of atrial fibrillation : Clinical implications. In: Journal of the American College of Cardiology. 2001 ; Vol. 37, No. 2. pp. 371-378.
@article{ee394ea777944f49bfafe55dee855b5a,
title = "Epidemiology and natural history of atrial fibrillation: Clinical implications",
abstract = "With a substantial impact on morbidity and mortality, the growing {"}epidemic{"} of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.",
author = "Chugh, {Sumeet S.} and Blackshear, {Joseph L.} and Shen, {Win Kuang} and Hammill, {Stephen C.} and Gersh, {Bernard J.}",
year = "2001",
doi = "10.1016/S0735-1097(00)01107-4",
language = "English (US)",
volume = "37",
pages = "371--378",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Epidemiology and natural history of atrial fibrillation

T2 - Clinical implications

AU - Chugh, Sumeet S.

AU - Blackshear, Joseph L.

AU - Shen, Win Kuang

AU - Hammill, Stephen C.

AU - Gersh, Bernard J.

PY - 2001

Y1 - 2001

N2 - With a substantial impact on morbidity and mortality, the growing "epidemic" of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.

AB - With a substantial impact on morbidity and mortality, the growing "epidemic" of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.

UR - http://www.scopus.com/inward/record.url?scp=0035134761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035134761&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(00)01107-4

DO - 10.1016/S0735-1097(00)01107-4

M3 - Article

C2 - 11216949

AN - SCOPUS:0035134761

VL - 37

SP - 371

EP - 378

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 2

ER -